Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock ...

Several other equities research analysts have also commented on the stock. UBS Group increased their price objective on shares of United Therapeutics from $415.00 to $475.00 and gave the company a ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

Strength Seen in Foghorn Therapeutics: Can Its 9.5% Jump Turn ... This compares to the stock's 43.2% gain over the past four weeks.

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...

Silver Spring, MD-based United Therapeutics Corporation markets four ... UTHR is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of B and VGM Score of A. Earnings are expected to grow ...

For new and old investors, taking full advantage of the stock market and investing ... Silver Spring, MD-based United Therapeutics Corporation markets four medicines in the United States to ...